000			02242cam a22005658i 4500
001			9781910419922
005			20250919150656.0
006			m eo d
007			cr cn |||m|||a
008			140721s2014 enk ob 001 0 eng d
020			_z9781910419915 _qprint : set
020			_z9781910419946 _qprint
020			_a9781910419908 _qePub: set
020			_a9781910419939 _qePub
020			_a9781910419892 _qeISBN: set
020			_a9781910419922 _qeISBN
024	7		_a10.4155/9781910419922 _2doi
035			_a(CaBNVSL)thg00911447
040			_aCaBNVSL _beng _erda _cCaBNVSL _dCaBNVSL
050		4	_aRM666.N87 _bA383 2014ebvol. 1
060		4	_aQU 58 _bA383 2014ebvol. 1
082	0	4	_a615.36 _223
245	0	0	_aAdvances and challenges in the delivery of nucleic acid therapeutics. _nVolume 1 / _ceditors, Olivia Merkel & Mansoor Amiji.
264		1	_aLondon, England : _bFuture Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK), _c[2014]
336			_atext _2rdacontent
337			_aelectronic _2isbdmedia
338			_aonline resource _2rdacarrier
490	1		_aThe Future Science Group eBook collection, _x2047-332X
504			_aIncludes bibliographical references and index.
506	1		_aRestricted to subscribers or individual electronic text purchasers.
530			_aAlso available in print.
538			_aSystem requirements: Adobe Acrobat Reader.
538			_aMode of access: World Wide Web.
588			_aTitle from PDF title page (Future Medicine eBooks Web site, viewed July 21, 2014).
650	1	2	_aDrug Delivery Systems.
650	1	2	_aNucleic Acids _xtherapeutic use.
650		0	_aDrug delivery systems.
650		0	_aNucleic acids _xTherapeutic use.
655		0	_aElectronic books.
700	1		_aAmiji, Mansoor M., _eeditor.
700	1		_aMerkel, Olivia, _eeditor.
710	2		_aFuture Science Ltd., _epublisher.
776	0	8	_iPrint version: _z9781910419946
830		0	_aFuture Science Group eBook collection, _x2047-332X.
856	4	0	_3Future Science Ltd. _uhttp://www.futuremedicine.com/doi/pdf/10.4155/9781910419922
907			_a.b17038091 _b2024-07-26 _c2024-07-22
942			_n0
998			_a1 _b2024-07-22 _cm _dz _feng _genk _y0 _z.b17038091
999			_c670450 _d670450